Advertisement

Colorectal Cancer

Preoperative Evaluation and Staging
Published:March 09, 2022DOI:https://doi.org/10.1016/j.soc.2021.12.001

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cunningham D.
        • Atkin W.
        • Lenz H.J.
        • et al.
        Colorectal cancer.
        Lancet. 2010; 375: 1030-1047
        • Haggar F.A.
        • Boushey R.P.
        Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.
        Clin Colon Rectal Surg. 2009; 22: 191-197
        • Cappell M.S.
        Pathophysiology, clinical presentation, and management of colon cancer.
        Gastroenterol Clin North Am. 2008; 37 (v): 1-24
        • Bibbins-Domingo K.
        • Grossman D.C.
        • Curry S.J.
        • et al.
        • US Preventive Services Task Force
        Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
        JAMA. 2016; 315: 2564-2575https://doi.org/10.1001/jama.2016.5989
        • Chang G.J.
        • Kaiser A.M.
        • Mills S.
        • et al.
        Practice parameters for the management of colon cancer.
        Dis Colon Rectum. 2012; 55: 831-843
        • Aarons C.B.
        • Mahmoud N.N.
        Current surgical considerations for colorectal cancer.
        Chin Clin Oncol. 2013; 2: 14
        • Engstrom P.F.
        • Arnoletti J.P.
        • Benson ABr
        • et al.
        NCCN Clinical Practice Guidelines in Oncology: colon cancer.
        J Natl Compr Canc Netw. 2009; 7: 778-831
        • Engstrom P.F.
        • Arnoletti J.P.
        • Benson ABr
        • et al.
        NCCN Clinical Practice Guidelines in Oncology: rectal cancer.
        J Natl Compr Canc Netw. 2009; 7: 838-881
        • Govindarajan R.
        • Shah R.V.
        • Erkman L.G.
        • et al.
        Racial differences in the outcome of patients with colorectal carcinoma.
        Cancer. 2003; 97: 493-498
        • Tammana V.S.
        • Laiyemo A.O.
        Colorectal cancer disparities: issues, controversies and solutions.
        World J Gastroenterol. 2014; 20: 869-876
        • Winawer S.J.
        • Stewart E.T.
        • Zauber A.G.
        • et al.
        A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group.
        N Engl J Med. 2000; 342: 1766-1772
        • Murphy C.C.
        • Lund J.L.
        • Sandler R.S.
        Young-Onset Colorectal Cancer: Earlier Diagnoses or Increasing Disease Burden?.
        Gastroenterology. 2017; 152: 1809-1812
        • Bhandari A.
        • Woodhouse M.
        • Gupta S.
        Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers.
        J Investig Med. 2017; 65: 311-315
        • Murphy C.C.
        • Singal A.G.
        • Baron J.A.
        • et al.
        Decrease in Incidence of Young-Onset Colorectal Cancer Before Recent Increase.
        Gastroenterology. 2018; 155: 1716-1719
        • Siegel R.L.
        • Fedewa S.A.
        • Anderson W.F.
        • et al.
        Colorectal Cancer Incidence Patterns in the United States, 1974-2013.
        J Natl Cancer Inst. 2017; 109: djw322
        • Done J.Z.
        • Fang S.H.
        Young-onset colorectal cancer: A review.
        World J Gastrointest Oncol. 2021; 13: 856-866
        • Moiel D.
        • Thompson J.
        Early detection of colon cancer-the Kaiser Permanente Northwest 30-year history: how do we measure success? Is it the test, the number of tests, the stage, or the percentage of screen-detected patients?.
        Perm J. 2011; 15: 30-38
        • Joseph D.A.
        • King J.B.
        • Miller J.W.
        • et al.
        Prevalence of colorectal cancer screening among adults--Behavioral Risk Factor Surveillance System, United States, 2010.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 51-56
        • Fleshman J.W.
        • Wolff B.G.
        The ASCRS textbook of colon and rectal surgery.
        Springer, New York2007
        • Majumdar S.R.
        • Fletcher R.H.
        • Evans A.T.
        How does colorectal cancer present? Symptoms, duration, and clues to location.
        Am J Gastroenterol. 1999; 94: 3039-3045
        • Amri R.
        • Bordeianou L.G.
        • Sylla P.
        • et al.
        Impact of screening colonoscopy on outcomes in colon cancer surgery.
        JAMA Surg. 2013; 148: 747-754
        • Lynch M.L.
        • Brand M.I.
        Preoperative evaluation and oncologic principles of colon cancer surgery.
        Clin Colon Rectal Surg. 2005; 18: 163-173
        • Mulder S.A.
        • Kranse R.
        • Damhuis R.A.
        • et al.
        Prevalence and prognosis of synchronous colorectal cancer: a Dutch population-based study.
        Cancer Epidemiol. 2011; 35: 442-447
        • Luigiano C.
        • Ferrara F.
        • Morace C.
        • et al.
        Endoscopic tattooing of gastrointestinal and pancreatic lesions.
        Adv Ther. 2012; 29: 864-873
        • Dawson K.
        • Wiebusch A.
        • Thirlby R.C.
        Preoperative tattooing and improved lymph node retrieval rates from colectomy specimens in patients with colorectal cancers.
        Arch Surg. 2010; 145: 826-830
        • Bartels S.A.
        • van der Zaag E.S.
        • Dekker E.
        • et al.
        The effect of colonoscopic tattooing on lymph node retrieval and sentinel lymph node mapping.
        Gastrointest Endosc. 2012; 76: 793-800
        • Compton C.C.
        • Fielding L.P.
        • Burgart L.J.
        • et al.
        Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.
        Arch Pathol Lab Med. 2000; 124: 979-994
        • Au F.C.
        • Stein B.S.
        • Gennaro A.R.
        • et al.
        Tissue CEA in colorectal carcinoma.
        Dis Colon Rectum. 1984; 27: 16-18
        • Fletcher R.H.
        Carcinoembryonic antigen.
        Ann Intern Med. 1986; 104: 66-73
        • McCall J.L.
        • Black R.B.
        • Rich C.A.
        • et al.
        The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer.
        Dis Colon Rectum. 1994; 37: 875-881
        • Wiratkapun S.
        • Kraemer M.
        • Seow-Choen F.
        • et al.
        High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study.
        Dis Colon Rectum. 2001; 44: 231-235
        • Huh J.W.
        • Oh B.R.
        • Kim H.R.
        • et al.
        Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer.
        J Surg Oncol. 2010; 101: 396-400
        • Kirat H.T.
        • Ozturk E.
        • Lavery I.C.
        • et al.
        The predictive value of preoperative carcinoembryonic antigen level in the prognosis of colon cancer.
        Am J Surg. 2012; 204: 447-452
        • Locker G.Y.
        • Hamilton S.
        • Harris J.
        • et al.
        ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
        J Clin Oncol. 2006; 24: 5313-5327
        • Park I.J.
        • Choi G.S.
        • Lim K.H.
        • et al.
        Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
        Ann Surg Oncol. 2009; 16: 3087-3093
        • Mauchley D.C.
        • Lynge D.C.
        • Langdale L.A.
        • et al.
        Clinical utility and cost-effectiveness of routine preoperative computed tomography scanning in patients with colon cancer.
        Am J Surg. 2005; 189 ([discussion: 517]): 512-517
        • Sahani D.V.
        • Bajwa M.A.
        • Andrabi Y.
        • et al.
        Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma.
        Ann Surg. 2014; 259: 861-872
        • Furukawa H.
        • Ikuma H.
        • Seki A.
        • et al.
        Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.
        Gut. 2006; 55: 1007-1011
        • Pelosi E.
        • Deandreis D.
        The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer.
        Eur J Surg Oncol. 2007; 33: 1-6
        • Whiteford M.H.
        • Whiteford H.M.
        • Yee L.F.
        • et al.
        Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
        Dis Colon Rectum. 2000; 43 ([discussion: 767–70]): 759-767
        • Edge S.B.
        • Byrd D.R.
        • Compton C.C.
        • et al.
        AJCC cancer staging manual.
        Springer, New York2010
        • Gollub M.J.
        • Schwartz L.H.
        • Akhurst T.
        Update on colorectal cancer imaging.
        Radiol Clin North Am. 2007; 45: 85-118
        • Flamen P.
        • Hoekstra O.S.
        • Homans F.
        • et al.
        Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET).
        Eur J Cancer. 2001; 37: 862-869
        • Ruers T.J.
        • Wiering B.
        • van der Sijp J.R.
        • et al.
        Improved selection of patients for hepatic surgery of colorectal liver metastases with (18) F-FDG PET: a randomized study.
        J Nucl Med. 2009; 50: 1036-1041
        • Deborah S.
        • Keller M.S.
        Staging of Locally Advanced Rectal Cancer Beyond TME.
        Clin Colon Rectal Surg. 2020; 33: 258-267
        • Amin M.B.
        • Greene F.L.
        • Edge S.B.
        • et al.
        The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
        CA Cancer J Clin. 2017; 67: 93-99
        • Compton C.C.
        Colorectal carcinoma: diagnostic, prognostic, and molecular features.
        Mod Pathol. 2003; 16: 376-388
        • Fleming M.
        • Ravula S.
        • Tatishchev S.F.
        • et al.
        Colorectal carcinoma: Pathologic aspects.
        J Gastrointest Oncol. 2012; 3: 153-173
        • Chang G.J.
        • Rodriguez-Bigas M.A.
        • Skibber J.M.
        • et al.
        Lymph node evaluation and survival after curative resection of colon cancer: systematic review.
        J Natl Cancer Inst. 2007; 99: 433-441
        • Ueno H.
        • Hashiguchi Y.
        • Shimazaki H.
        • et al.
        Peritumoral deposits as an adverse prognostic indicator of colorectal cancer.
        Am J Surg. 2014; 207: 70-77
        • Rullier A.
        • Laurent C.
        • Capdepont M.
        • et al.
        Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival.
        Am J Surg Pathol. 2008; 32: 45-50
        • Nelson H.
        • Petrelli N.
        • Carlin A.
        • et al.
        Guidelines 2000 for colon and rectal cancer surgery.
        J Natl Cancer Inst. 2001; 93: 583-596
        • Quirke P.
        • Steele R.
        • Monson J.
        • et al.
        • MRC CR07/NCIC-CTG CO16 Trial Investigators., NCRI Colorectal Cancer Study Group
        Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.
        Lancet. 2009; 373: 821-828
        • Aarons C.B.
        • Shanmugan S.
        • Bleier J.I.
        Management of malignant colon polyps: current status and controversies.
        World J Gastroenterol. 2014; 20: 16178-16183
        • Bujanda L.
        Malignant colorectal polyps.
        WJG. 2010; 16: 3103
        • Hassan C.
        • Zullo A.
        • Risio M.
        • et al.
        Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis.
        Dis Colon Rectum. 2005; 48: 1588-1596
        • Tominaga K.
        • Nakanishi Y.
        • Nimura S.
        • et al.
        Predictive Histopathologic Factors for Lymph Node Metastasis in Patients With Nonpedunculated Submucosal Invasive Colorectal Carcinoma.
        Dis Colon Rectum. 2005; 48: 92-100
        • Coppede F.
        • Lopomo A.
        • Spisni R.
        • et al.
        Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
        World J Gastroenterol. 2014; 20: 943-956
        • Gausachs M.
        • Mur P.
        • Corral J.
        • et al.
        MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.
        Eur J Hum Genet. 2012; 20: 762-768
        • Kurzawski G.
        • Suchy J.
        • Debniak T.
        • et al.
        Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool.
        Ann Oncol. 2004; 15: iv283-iv284
        • Benatti P.
        • Gafa R.
        • Barana D.
        • et al.
        Microsatellite instability and colorectal cancer prognosis.
        Clin Cancer Res. 2005; 11: 8332-8340
        • Ribic C.M.
        • Sargent D.J.
        • Moore M.J.
        • et al.
        Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
        N Engl J Med. 2003; 349: 247-257
        • Adamina M.
        • Buchs N.C.
        • Penna M.
        • et al.
        • St.Gallen Colorectal Consensus Expert Group
        St.Gallen consensus on safe implementation of transanal total mesorectal excision.
        Surg Endosc. 2018; 32: 1091-1103